Illumina rejects latest Roche offer
Healthcare group and its Swiss suitor on collision course ahead of US targets annual shareholders meeting on April 18
Source: Pharmaceuticals companies news from the Financial Times
Roche abandons pursuit of Illumina
US genetics group's shares fall after Swiss pharmaceutical company chairman says an acquisition deal is definitely off the table
Source: Pharmaceuticals companies news from the Financial Times